Ignacio
Gil Bazo
Ikertzailea 2022-(e)ra arte
Queen Elizabeth Hospital
Adelaida, AustraliaQueen Elizabeth Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2019
-
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology, Vol. 20, Núm. 12, pp. 1655-1669